Healthcare providers, managed care entities, and life sciences companies each face unique situations when analyzing strategic options and often require assistance to help them navigate toward the decision that will most benefit all stakeholders. When the decision turns to a potential transaction, clients desire an end-to-end, comprehensive transaction advisory solution to meet their needs, which is why Navigant offers a seamless service offering that includes strategy, valuation, and investment banking professionals who specialize in the healthcare and life sciences sector.
Navigant’s dedicated healthcare and life sciences strategy consulting experts can provide a full strategic assessment supported by rigorous financial analytics that will assist our clients with a solid basis for making critical strategic decisions related to their business or business segment. Some companies may be enjoying robust growth or looking to grow through acquisition, in which case they need a partner or some fresh capital. Others may be in a consolidation mode and require advisory and execution services to provide liquidity. Once the decision is made to retain, merge, acquire, sell, joint venture, or partner, Navigant’s valuation and investment banking professionals can seamlessly assist with subsequent stages of the process, including due diligence, pricing analysis, valuation analysis, private capital raising, fairness opinions, deal execution, post-closing valuation analysis, transition support, and integration.
If a capital raise or an acquisition or sale strategy is selected, our wholly-owned broker/dealer subsidiary, Navigant Capital Advisors, LLC (member FINRA/SIPC) would shoulder the responsibility for the acquisition or sale process.
Transaction advisory services offered by Navigant and Navigant Capital Advisors include: